Genentech: The Beginnings of Biotech, by Sally Smith Hughes, is an incredibly informative book about the unorthodox creation and ingenuity of the company Genentech, Inc. This book, albeit slow and clunky to read at times, reveals to its readers the minutiaes, controversies, and successes of business, biotechnology, genetics, biology, corporations, patenting, politics, and academia when they are all mixed together. Hughes’ book is aimed at the scientific community, and anyone else who may be interested in science: notably genetics and biotechnology. The single commanding genre of this book would definitely be associated with genetic innovation in the field of biotechnology. Hughes does an adequate job at bringing to light the revolutionary breakthrough and aftermath of recombinant DNA discovery and research in the mid-1970s. Continue reading “Genentech: When Science Stumbles into Business”
Genentech: The Beginnings of Biotech is a book that tells the story of how Genentech, one of the first biotechnology companies, was founded. It tells the story of how “The company inspired a new industrial sector transforming the biomedical and commercial landscapes ever after” (Hughes Prologue 1). It is written by Sally Smith Hughes, a historian of science at the Bancroft Library at the University of California, Berkeley. She is the author of The Virus: A History of the Concept and Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology (“Sally Smith Hughes” 2012). She has lots of experience detailing the history of scientific processes and companies as she is also the creator of an extensive collection of in-depth oral histories on bioscience, biomedicine, and biotechnology. This shows in her book about Genentech, as she is able to provide lots of information on the key figures in the company’s start-up, such as Herb Boyer, Stanley Cohen, and Robert Swanson. She is also able to describe the scientific processes that made the company successful such as the use and discovery of recombinant DNA. Continue reading “Genentech: A Science-Business Hybrid”
Do you ever wonder what it takes for a company to be successful? Sally Smith Hughes’ book, Genentech: The Beginnings of Biotech, answers this question with an inside look at the makings of Genentech, a California-based biotech company, and their quest to make human insulin and growth hormone commercialized. Hughes has established herself as an academic scholar through her study of the history of science and her oral stories such as “Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology” as she looks into discoveries and commercialization (Berkeley). Similarly, in Genentech, she integrates scientific, legal and corporate ideas to portray the biotech startup and challenges it faced. The most important challenges are competition, patentability, and partnerships with corporate companies, all of which Hughes uses to give readers who are unfamiliar with these fields a better understanding. Continue reading “The Success of Genentech: Integrating Science, Law, and Corporate Business”
Sally Smith Hughes is an Academic Specialist in History of Science. She studied at the University of California, Berkley. She does research in biology which reflect her areas of interest. Moreover, she published a book called Genentech: The Beginnings of Biotech. This book focuses on the beginning of the company Genentech. The company struggled through various obstacles including obstacles with the government and within the company. In the prologue the author notes, “The making of Genentech was in fact racked by problems, internal and external” (i). Despite of all the obstacles, the company managed to grow and make life changing discoveries.
The two founders of Genentech Stanley Cohen and Herbert Boyer both worked on the basic-research techniques. However, “they immediately foresaw its practical applications in making plentiful quantities of insulin, growth hormone, and other useful substances in bacteria,” (1). This brought internal problems because they started seeing a different direction of what they wanted to discover. Some wanted to go straight to the discovery of insulin, while others wanted to discover somatostatin. Even though it wasn’t as a strong fight as the others, their differences started to show. Their problems grew when they started publishing articles, “Then a heated dispute over authorship broke out,” (65). The more they were able to do, the more complicated it became for them. Robert Swanson started helping in managing the company and focused on getting financial security for the company. Nevertheless, some did not love the way he managed things. The author notes, “As his severest critics put it, he was ‘selling out to the industry,’” (71). It is obvious that working in such a huge project isn’t easy, and all of their fights proved that. Continue reading “The full spectrum of scientific ingenuity”